Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US

Introduction: This study evaluated the cost-effectiveness of atezolizumab + chemotherapy vs. chemotherapy as first-line treatment for extensive-stage small-cell lung cancer (SCLC) in the United States (US). Methods: The three health states partitioned survival (PS) model was used over the lifetime....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Public Health
Main Authors: Wang, Yingcheng, Rui, Mingjun, Yang, Lan, Wang, Xintian, Shang, Ye, Ma, Aixia, Li, Hongchao
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2021
Assuntos:
Public Health
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8055835/
https://ncbi.nlm.nih.gov/pubmed/33889559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpubh.2021.650392
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares